Rhabdomyolysis after recombinant zoster vaccination: a rare adverse reaction

被引:9
作者
Rajaratnam, Nishan [1 ]
Govil, Swati [1 ]
Patel, Rutwik [1 ]
Ahmed, Mohamed [1 ]
Elias, Sameh [1 ]
机构
[1] Hackensack Meridian Hlth Palisades Med Ctr, Dept Med, North Bergen, NJ 07047 USA
关键词
Rhabdomyolysis; zoster; shingles; vaccine; vaccination; adverse effect;
D O I
10.1080/20009666.2020.1841878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a case report describing a potential rare adverse reaction of the recombinant zoster vaccination. This patient is a 60-year-old female who was admitted for severe rhabdomyolysis after receiving the vaccine. The patient's symptoms and CPK improved with aggressive hydration over several days. The patient did not have any known or reported common risk factors for rhabdomyolysis and the Naranjo Score was used to determine the likelihood of an adverse drug reaction. This is a relevant case to discuss in order to make physicians aware of a possible rare and lethal adverse effect due to a common vaccination.
引用
收藏
页码:145 / 146
页数:2
相关论文
共 9 条
[1]   Rhabdomyolysis secondary to influenza A H1N1 vaccine resulting in acute kidney injury [J].
Callado, Rodrigo Barbosa ;
Ponte Carneiro, Tassia Gabrielle ;
da Cunha Parahyba, Camille Carneiro ;
Lima, Neiberg de Alcantara ;
da Silva Junior, Geraldo Bezerra ;
Daher, Elizabeth de Francesco .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2013, 11 (02) :130-133
[2]   Post-vaccination myositis and myocarditis in a previously healthy male [J].
Cheng, Matthew P. ;
Kozoriz, Michael G. ;
Ahmadi, Amir A. ;
Kelsall, John ;
Paquette, Katryn ;
Onrot, Jake M. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2016, 12
[3]  
Hesse EM, 2019, MMWR-MORBID MORTAL W, V68, P91, DOI 10.15585/mmwr.mm6804a4
[4]   Rhabdomyolysis Secondary to Tetanus Toxoid Administration in a Patient Following Minor Laceration [J].
Hursitoglu, Mehmet ;
Cikrikcioglu, Mehmet Ali ;
Gundogan, Erdal ;
Ozkan, Oktay ;
Cordan, Ilker ;
Yigit, Yildiz ;
Kara, Osman ;
Soysal, Pinar ;
Rabus, Sule Apikoglu ;
Celepkolu, Tahsin ;
Tukek, Tufan .
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) :110-111
[5]   Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine [J].
James, Stephanie F. ;
Chahine, Elias B. ;
Sucher, Allana J. ;
Hanna, Cassandra .
ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) :673-680
[6]   A Risk Prediction Score for Kidney Failure or Mortality in Rhabdomyolysis [J].
McMahon, Gearoid M. ;
Zeng, Xiaoxi ;
Waikar, Sushrut S. .
JAMA INTERNAL MEDICINE, 2013, 173 (19) :1821-1828
[7]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[8]   Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects [J].
Perricone, Carlo ;
Colafrancesco, Serena ;
Mazor, Roei D. ;
Soriano, Alessandra ;
Agmon-Levin, Nancy ;
Shoenfeld, Yehuda .
JOURNAL OF AUTOIMMUNITY, 2013, 47 :1-16
[9]   Herpes zoster vaccine live: A 10 year review of post-marketing safety experience [J].
Willis, English D. ;
Woodward, Meredith ;
Brown, Elizabeth ;
Popmihajlov, Zoran ;
Saddier, Patricia ;
Annunziato, Paula W. ;
Halsey, Neal A. ;
Gershon, Anne A. .
VACCINE, 2017, 35 (52) :7231-7239